Food

RE+ 2024: Ampace to Spotlight UniC Series and Introduce Industry-First Technology to the Americas for the First Time

ANAHEIM,Calif.,Sept. 2,2024-- With the rapid development of technology,innovative energy solutions are becoming the focus of global attention. As a new energy technology innovation company,Ampace comm

Frost Radar™ Positions 14 Top Growth & Innovation Leaders in Global Healthcare Data Interoperability

Frost & Sullivan\'s Benchmarking System Highlights Leading Companies Poised for Growth and Advancing Healthcare Interoperability

Viomi Technology Co., Ltd Announces Completion of Certain IoT@Home Businesses Divestment

GUANGZHOU,China,Aug. 31,2024-- Viomi Technology Co.,Ltd ("Viomi" or the "Company") (NASDAQ: VIOT),a leading technology company for home water solutions in China,today announced tha

OMODA 7 Records 8.0 Acceleration Time during an Extreme Heat Test Performed by OMODA CEO

OMODA 7,the latest compact crossover SUV of OMODA and JAECOO,is coming to the Philippines in the near future.

Silkland Launches First 16K VESA-Certified USB C to DisplayPort 2.1 Cable on Amazon

NEW YORK,Sept. 3,2024-- Silkland,a tech brand specializing in cables and accessories,has released the first-ever 16K VESA-certified USB C to DisplayPort 2.1 cable to support the future of visual displ

Committed to Deliver Marvelous Experience to Indonesians, Indosat Ooredoo Hutchison Complete the World's First Large PS Core Network Consolidation & Transformation

JAKARTA,Indonesia,Aug. 28,2024--Indosat Ooredoo Hutchison (Indosat or IOH),the most preferred digital telco of Indonesia,in cooperation with global ICT solution provider Huawei,has finalized a large c

DPC Dash Ltd Announces 2024 Interim Financial Results

Revenues increased to RMB2.04 billion,representing 48.3% year-over-year growth Adjusted net profit reached RMB50.9 million,from an adjusted net loss of RMB17.4 million in the same period of 2023

Akeso's 2024 First Half Interim Results: Expanding Global Lead in IO Bispecific Antibodies, Advancing New Therapies, and Accelerating Commercialization

Approval of ivonescimab for 2L+ EGFRm NSCL; HARMONi-A is the only phase III study that demonstrates significant benefit across all subgroups for PFS,and is also the only study to achieve the primary e

UTime Signs NDA to Acquire Monkeypox Vaccine Maker Bowen Therapeutics Inc and Supports Completion of FDA Registration of Related Vaccines

SHENZHEN,China,Aug. 28,2024-- UTime Limited (NASDAQ:WTO) ("UTime" or the "Company")has officially announced the signing of a non-disclosure agreement (the "NDA") with Bow

Babilou Family Singapore Empowers Educators with Global Best Practices Through Inter-Country Learning Journey Initiative

The initiative provides opportunities forBabilou Family Singapore\'s early childhood educators to share best practices,equipping them with global insights.

Home Previous 32 33 34 35 36 37 38 Next Tail

10 Items Per Page (Page 35 / 39) Total 390 Items

©copyright2009-2020North American Event Live Network      Contact Us   SiteMap